CYTH logo

Cyclo Therapeutics (CYTH) EV/EBITDA

EV/EBITDA

-1.28
-0.01-0.79%

34 min ago


Summary


Performance

CYTH EV/EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

OtherCYTHvaluationmetrics:

EV/EBITDA Formula

EV/EBITDA =  
Enterprise Value
TTM EBITDA

CYTH EV/EBITDA Trends

PeriodPeriodEV/EBITDAEV/EBITDAEnterprise valueEnterprise valuePricePrice
todaytoday-0.8%+0.5%+0.7%
1 m1 month+15.2%-15.1%-21.7%
3 m3 months-10.3%+10.6%+17.5%
6 m6 months-28.0%+49.6%+5.2%
ytdytd-16.4%+16.4%+28.1%
1 y1 year+32.6%-17.1%-56.5%
5 y5 years+20.5%+166.2%-94.1%

CYTH EV/EBITDA Highs & Lows

PeriodPeriodHighHighCurrent vs highvs highLowLowCurrent vs lowvs low
1 m1-month-0.8%-1.68+23.8%
3 m3-month-1.10-16.4%-1.85+30.8%
6 m6-month-0.96-33.3%-1.85+30.8%
1 y1-year-0.96-33.3%-2.08+38.5%
3 y3-year-0.28-357.1%-2.33+45.1%
5 y5-year-0.28-357.1%-7.42+82.8%
alltimeall time275.70-100.5%-11 K+100.0%

Cyclo Therapeutics EV/EBITDA History

DateValue
2025
-1.28(+16.4%)
2024
-1.10(-37.9%)
2023
-1.77(+164.2%)
2022
-0.67(-36.2%)
2021
-1.05(+15.4%)
2020
-0.91(-82.6%)
2019
-5.23(-68.5%)
2018
-16.58(+162.3%)
2017
-6.32(-7.2%)
DateValue
2016
-6.81(-51.3%)
2015
-13.97(-82.9%)
2014
-81.76(-1106.9%)
2013
8.12(-57.2%)
2012
18.97(-114.6%)
2011
-130.08(-179.2%)
2010
164.27(-950.3%)
2009
-19.32(+938.7%)
2008
-1.86

FAQ

  • What is Cyclo Therapeutics EV/EBITDA?
  • What is the all time high EV/EBITDA for Cyclo Therapeutics?
  • What is CYTH EV/EBITDA year-to-date change?
  • What is Cyclo Therapeutics EV/EBITDA year-on-year change?

What is Cyclo Therapeutics EV/EBITDA?

The current EV/EBITDA of CYTH is -1.28

What is the all time high EV/EBITDA for Cyclo Therapeutics?

Cyclo Therapeutics all-time high EV/EBITDA is 275.70

What is CYTH EV/EBITDA year-to-date change?

Cyclo Therapeutics EV/EBITDA has changed by -0.18 (-16.36%) since the beginning of the year

What is Cyclo Therapeutics EV/EBITDA year-on-year change?

Over the past year, CYTH EV/EBITDA has changed by +0.62 (+32.63%)